申请人:Fyfe Matthew Colin Thor
公开号:US20090099227A1
公开(公告)日:2009-04-16
Compounds of Formula (I) or pharmaceutically acceptable salts or N-oxides thereof, are agonists of GPR116 and are useful for the treatment of obesity, and for the treatment of diabetes.
化合物式(I)或其药学上可接受的盐或N-氧化物,是GPR116激动剂,可用于治疗肥胖症和糖尿病的治疗。